+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


The Renaissance of Cancer Immunotherapy. The 7th International Cancer Vaccine Symposium, Volume 1284. Annals of the New York Academy of Sciences

  • ID: 2586723
  • Book
  • Region: Global, New York
  • 252 Pages
  • John Wiley and Sons Ltd
1 of 3
This Annals volume includes invited short reviews on topics presented at the 7th International Cancer Vaccine Symposium Renaissance of Cancer Immunotherapy , held September 9–11, 2012 in Florence, Italy.  The papers cover the latest progress in basic immunology research and its translation to cancer patients.  The meeting and papers pay tribute to the successes in the last few years that have led to the approval of new immunotherapies and the awarding of the Nobel Prize in medicine to three immunologists.  The symposium is dedicated to one of these recipients, Dr. Ralph Steinman who discovered dendritic cells, immune cells that are vital in immune responses and immunotherapies for cancer.

NOTE: Annals volumes are available for sale as individual books or as a journal. For more information on institutional journal subscriptions, please visit: Annals online and discounts on print volumes. Please visit <a href="[external URL] for more information on becoming a member.
Note: Product cover images may vary from those shown
2 of 3

Introduction to The Renaissance of Cancer Immunotherapy vOlivera J. Finn and Gerold Schuler

Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy 1Matthews D. Vesely and Robert D. Schreiber

Cell–extrinsic effects of the tumor unfolded protein response on myeloid cells and T cells 6Maurizio Zanetti

Immunotherapy in preneoplastic disease: targeting early procarcinogenic inflammatory changes that lead to immune suppression and tumor tolerance 12Bridget Keenan and Elizabeth M. Jaffee

Integration of epidemiology, immunobiology, and translational research for brain tumors 17Hideho Okada, Michael E. Scheurer, Saumendra N. Sarkar, and Melissa L. Bondy

Human dendritic cells subsets as targets and vectors for therapy 24Eynav Klechevsky and Jacques Banchereau

Dendritic cell immunotherapy 31Rachel Lubong Sabado and Nina BhardwajMolecular programming of steady–state dendritic cells: impact on autoimmunity and tumor immune surveillance 46Dylan J. Johnson and Pamela S. Ohashi

Preventing cancer by targeting abnormally expressed self–antigens: MUC1 vaccines for prevention of epithelial adenocarcinomas 52Pamela L. Beatty and Olivera J. Finn

Immunological control of cell cycle aberrations for avoidance of oncogenesis: the case of tetraploidy 57Laura Senovilla, Lorenzo Galluzzi, Maria Castedo, and Guido Kroemer

Ongoing adaptive immune responses in the microenvironment of melanoma metastases 62Nicolas van Baren and Pierre G. Coulie

Main features of human T helper 17 cells 66Francesco Annunziato, Lorenzo Cosmi, Francesco Liotta, Enrico Maggi, and Sergio Romagnani

In silico modeling of cancel cell dissemination and metastasis 71Lu–En Wai, Vipin Narang, Alexandre Gouaillard, Lai Guan Ng, and Jean–Pierre Abastado

Common pathways to tumor rejection 75Ena Wang, Davide Bedognetti, Sara Tomei, and Francesco M. Marincola

Cancer–induced immunosuppressive cascades and their reversal by molecular–targeted therapy 80Yutaka Kawakami, Tomonori Yaguchi, Hidetoshi Sumimoto, Chie Kudo–Saito, Nobuo Tsukamoto. Tomoko Iwata–Kajihara, Shoko Nakamura, Hiroshi Nishio, Ryosuke Satomi, Asuka Kobayashi, Mayuri Tanaka, Jeong Hoon Park, Hajime Kamijuku, Takahiro Tsujikawa, and Naoshi Kawamura

Note: Product cover images may vary from those shown
3 of 3


4 of 3
Olivera J. Finn
Gerold Schuler
Note: Product cover images may vary from those shown